Scaling Peptides Without Shutdowns — 17.52x ROAS Delivered
We run paid campaigns for multiple clients in the peptide niche. Even in one of the toughest verticals on Meta, we’re hitting 17x returns with stable delivery and zero shutdowns.
Anyone in the peptide space knows the struggle:
• Ads don’t pass review.
• Accounts get flagged within days.
• Scale feels impossible because every win is temporary.
That’s where our system comes in. We’ve built campaigns specifically for high-risk verticals like peptides, where the margin for error is razor-thin. Instead of chasing “blackhat tricks” that burn out fast, we run with policy-first frameworks that keep ads live and profitable.
The approach is simple but powerful:
Messaging built for compliance — no hype, no medical claims, just clean angles that pass review.
Native creatives — assets that blend naturally into feeds and stories while still pulling clicks.
Intent-based targeting — focusing on warm pools and lookalikes proven to buy, not broad wasted reach.
A lean funnel — ad → product page → checkout, optimized for trust and speed.
The result? Consistent delivery, profitable scaling, and — most importantly — campaigns that last. Our peptide clients aren’t fighting bans every week; they’re watching clean revenue roll in at enterprise-level ROAS.
This isn’t theory. It’s happening live, across multiple peptide accounts we manage, and it’s why we can confidently say: peptides scale when you run them the right way.
Want Similar Results?
If you’re selling peptides or other restricted health offers, our framework is already live and delivering. No bans, no wasted spend — just stable campaigns and profitable growth.
We’ve proven it across multiple peptide accounts. The next success story could be yours.
1-tap message us:
Subscribe to get insider case studies, real dashboards, and breakdowns of how we scale lead gen in the hardest niches.
Join free — or upgrade for exclusive deep dives.
Related Case Studies
🔹 This ‘Unstoppable’ WhatsApp Funnel Survived Gambling — and Just Crushed IPTV: 476 Leads at $3.64
How we adapted a gambling-proof funnel to scale IPTV sales with zero bans.
🔹 How We Generated 1,000+ IPTV Signups on Meta Ads (Italian Campaign)
The system behind Italy’s highest-converting IPTV signup campaign.
🔹440+ Finance Leads at $12.80 — How Zero Penny Did It Without a Landing Page
How we generated high-intent finance leads using form-based funnels and zero-page friction.
🔹1800+ Signups, $1+ Cost, and Strong FTDs – The Edge Every Casino Needs
(duplicate — left intentionally in case it’s needed in two locations)
🔹10,556 Targeted Leads at 1/14th the Average CPC
A complex, multi-platform campaign that delivered results in a heavily restricted vertical.
🔹2,771 Debt-Relief Leads from Latin America — With $0 Wasted
How we navigated Meta’s restrictions to drive thousands of verified leads for a financial product.
🔹GVF: The Funnel Behind 900+ WhatsApp Leads in Blackhat Finance
How we created a lead-gen machine for a blackhat vertical, delivered on WhatsApp without bans.
Remarkable execution on one of Meta's toughest verticals.
Your policy-first framework is what separates sustainable growth from the constant ban cycle most peptide sellers face. The emphasis on compliance-driven messaging without medical claims shows real sophistication. Too many agencies still chase loopholes instead of building systems that last.
What really stands out is your lean funnel approach. Eliminating friction between ad and checkout is critical in high-scrutiny niches where trust signals matter more than elaborate landing pages. The 17.52x ROAS proves this works at scale, not just for one-off campaigns.
I'm curious about your creative refresh cadence. In verticals this sensitive, do you rotate assets proactively to avoid ad fatigue flags, or do you let performance dictate when to iterate? Also, how aggresive are you with lookalike expansion once you've identified high-intent buyer pools? The balance between scale and account health seems especially delicate here.